FUJIFILM continues to innovate healthcare IT with Synapse VNA at HIMSS15

Stamford, C.T., April 8, 2015 (Booth #3402)FUJIFILM Medical Systems U.S.A., Inc. continues to expand its healthcare IT portfolio, and is taking Vendor Neutral Archive (VNA) into new areas with Synapse® VNA by further enhancing the patient imaging record at the 2015 annual meeting of the Healthcare Informatics Management Systems Society (HIMSS) conference and exhibit from April 13 -16 in Chicago, IL. Recognized globally as a premier conference in healthcare , HIMSS brings the industry’s brightest and most dynamic thought–leaders together to share ideas on the latest innovations in healthcare information technology.

“Fujifilm continues to provide innovation to meet its goal of creating superior healthcare experiences and improving patient outcomes,” said Jim Morgan, Vice President of Medical Informatics at FUJIFILM Medical Systems U.S.A., Inc. “Synapse VNA will enhance image management, streamline workflow, reduce costs and, most importantly, improve patient care. By listening to management teams and I.T. professionals, and leveraging Fujifilm’s broad experience in healthcare imaging domains, Fujifilm is creating a powerful new solution with Synapse VNA.   This addresses the clinical departmental needs of image management and allows IT the tools to centralize organizational imaging.”

Synapse VNA is a patient-centric application neutral highly scalable organizational image content management solution.  It can be completely virtualized with existing server architecture and is open to leverage current or planned physical storage environments. It is unique in its multiple methods of EHR patient associated content capture and ability to store content in its native format supporting both DICOM and Non-DICOM. Fujifilm also leverages over 50 years of experience in imaging areas like radiology, cardiology, endoscopy, and point of care ultrasound to uniquely streamline VNA capture workflows.

A VNA solution is not complete without an enterprise viewer capable of displaying all of the image types stored to the VNA, with the appropriate tools based on the viewing physician type or department, and ZERO PC requirements. Fujifilm will also showcase its Synapse Mobility Enterprise Viewer to expand VNA image access across entire health system.

To register for a product demonstration at HIMSS, please click here.  For more information about Synapse, please visit: www.fujimed.com .

About Fujifilm 
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women’s health imaging systems, Fujifilm has products that are ideal for any size imaging environment. The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc. supplies high quality, technologically advanced FUJINON brand endoscopes to the medical market. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information please visit www.fujimed.com and www.fujifilmendoscopy.com.

FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation and leading-edge products to a broad spectrum of industries, including: healthcare, with medical systems, pharmaceuticals and cosmetics; graphic systems; highly functional materials, such as flat panel display materials; optical devices, such as broadcast and cinema lenses; digital imaging; and document products. These are based on a vast portfolio of chemical, mechanical, optical, electronic, software and production technologies.  In the year ended March 31, 2014, the company had global revenues of $23.9 billion, at an exchange rate of 102 yen to the dollar. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.